Spironolactone Tablet
Product Images NDC 72603-135

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 72603-135). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Spironolactone Fig1)

This appears to be a table or graph showing data on the use of Spironolactone compared to a placebo in a study involving 822 participants who received Spironolactone and 841 participants who received a placebo. The data is related to probability and includes a log-rank p-value of < 0001. The numbers 02, 01, 00, B, and T 2 are also included, but their significance is unclear without additional context. The timeframe for the study appears to be 18-24 months.*

FDA Label Image

Fig2 (Spironolactone Fig2)

This appears to be a table with various parameters such as age, race, heart failure, diabetes, kidney function, potassium level, medications (such as digoxin, beta blockers, and spironolactone), and HR (heart rate) and 95% CI (confidence interval) values. The table seems to be comparing spironolactone and placebo in terms of efficacy.*

FDA Label Image

Package Label-principal Display Panel (25 mg (100 Tablets Bottle))

Each tablet of this medicine contains 25 mg of Spironolactone USP and is manufactured by Aurobindo Pharma Limited. The medicine comes in a container that is child-resistant and light-resistant. The usual dosage information is provided in the accompanying prescribing information. The medicine is sold in a pack containing 100 tablets. The manufacturing company is Northstar Rx LLC based in Memphis, TN 38141. The given NDG number is 72603-134-01, and the M.LNo. is 19/HD/AP/95/F/R, dated 03/2023.*

FDA Label Image

Package Label-principal Display Panel (50 mg (100 Tablets Bottle))

Each tablet contains 50 mg of Spironolactone USP manufactured by Northstar Rx LLC in Memphis, TN. The usual dosage is provided in the accompanying prescribing information. The tablets are dispensed in child-resistant containers and should be stored at 20° to 25°C. The manufacturer is Aurobindo Pharma Limited in Hyderabad, India. The lot number is 19/HD/AP/95/F/R and the expiration date is March 2023. No information is available about the overprinting zone and goding area.*

FDA Label Image

Package Label-principal Display Panel (100 mg (100 Tablets Bottle))

NDC 72603-136-01 is a medication containing Spironolactone in the form of tablets. Each tablet contains 100 mg of Spironolactone USP, and the recommended dosage can be found in the accompanying prescribing information. The tablets should be dispensed in tight and child-resistant containers and stored in a place protected from light at a temperature between 20° to 25°C (68° to 77°F). This product is manufactured for Northstar Rx LLC by Aurobindo Pharma Limited in Hyderabad-500 090, India. The text includes identifiers, dosage information, storage instructions, and the manufacturing information of the medication.*

FDA Label Image

Str1 (Spironolactone Str1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.